BIOMAT Database Logo BIOMAT Database Logo

[Content of nicotinamide coenzymes, metabolites and the NAD-dependent dehydrogenase activity in the blood in arteriosclerosis]. 1980

F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva

Study of the key mechanisms, metabolism regulators, showed that in the blood of patients with atherosclerosis the NAD/NAD . N ratio decreases by 59.8% and the NAD+ concentration by 44%, while the NAD . N content increases by 56.7%. In the nicotinamide adenine dinucleotide system there is a general tendency tomards accumulation:the concentration of NADP+ grows by 218.6% and that of NADP . N by 12.9%. A marked increase in the content of incompletely oxidized products is determined: lactic acid by 37.4%, alpha-glycerophosphate by 49.8%, dihydroxyacetone phosphate by 155%, oxaloacetate by 131% in the presence of lactate dehydrogenase and malate dehydrogenase activation. The detected changes are evidence of tissue energy debt in atherosclerosis, they reflect the character of metabolic acidosis formation and point to the presence of conditions for intensified liposynthesis.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008291 Malate Dehydrogenase An enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37. Malic Dehydrogenase,NAD-Malate Dehydrogenase,Dehydrogenase, Malate,Dehydrogenase, Malic,Dehydrogenase, NAD-Malate,NAD Malate Dehydrogenase
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D009247 NADH, NADPH Oxidoreductases A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. Oxidoreductases, NADH, NADPH,NADPH Oxidoreductases NADH,Oxidoreductases NADH, NADPH
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005994 Glycerophosphates Any salt or ester of glycerophosphoric acid. Glycerolphosphate,Glycerophosphate,Calcium Glycerophosphate,Glycerolphosphates,Glycerophosphate, Calcium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[Effect of antianginal agents on nicotinamide coenzyme content and NAD-dependent dehydrogenase activity].
January 1980, Farmakologiia i toksikologiia,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[The content of nicotinamide coenzymes NAD and NADH, and the adenyl system in diabetics].
January 1972, Vutreshni bolesti,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[Metabolism of nicotinamide coenzymes following total-body irradiation. I. Catabolism of NAD and excretion of its metabolites].
June 1969, Strahlentherapie,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[Content of nicotinamide coenzymes in rat liver under conditions of nicotinamide administration].
January 1977, Ukrains'kyi biokhimichnyi zhurnal,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[Nicotinamide coenzyme (NAD and NAD-H2) content in the blood of premature infants with intracranial birth injury].
August 1979, Pediatriia,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
Conformations of the coenzymes and the allosteric activator, ADP, bound to NAD(+)-dependent isocitrate dehydrogenase from pig heart.
May 1990, Biochemistry,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in human endometrium.
January 1980, Prostaglandins,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[The effect of nicotinamide, ascorbic acid and galascorbin on NAD and NADP dependent dehydrogenase activity in heart tissues with adrenaline induced myocarditis].
January 1971, Ukrains'kyi biokhimichnyi zhurnal,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
Nicotinamide coenzymes in heart and coronary blood during myocardial infarction.
January 1974, The American journal of physiology,
F N Gil'miiarova, and V N Fatenkov, and Z Kh Tenisheva, and V M Radomskaia, and T K Khal'meeva
[Effect of central cholinolytics spasmolytin and amysil on the content of nicotinamide coenzymes].
August 1976, Vrachebnoe delo,
Copied contents to your clipboard!